PLASMA CELL MYELOMA

Clinical trials for PLASMA CELL MYELOMA explained in plain language.

Never miss a new study

Get alerted when new PLASMA CELL MYELOMA trials appear

Sign up with your email to follow new studies for PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

New drug cocktail aims to wipe out hidden myeloma cells after transplant

Disease control Ongoing

This study tests whether a combination of belantamab mafodotin (a targeted chemotherapy) and lenalidomide can eliminate leftover cancer cells in multiple myeloma patients who still have signs of disease after a stem cell transplant. The goal is to achieve a state called minimal r…

Matched conditions: PLASMA CELL MYELOMA

Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated Apr 29, 2026 04:27 UTC

PLASMA CELL MYELOMA

Get alerted when new PLASMA CELL MYELOMA trials appear

New drug cocktail aims to wipe out hidden myeloma cells after transplant